PEAPACK, NJ — April 10, 2002 — The newest COX-2 specific inhibitor, Bextra® (valdecoxib tablets), is now available nationwide for the treatment of the signs and symptoms of osteoarthritis (OA), adult rheumatoid arthritis (RA), and the treatment of painful menstrual cramping.
Pharmacia Corporation and Pfizer Inc today announced the availability of the new medicine, which was approved by the U.S. Food and Drug Administration in late 2001. A once-daily 10 mg dose of Bextra offers 24-hour pain relief for both OA and RA.
For menstrual pain, the recommended dose of Bextra is 20 mg, administered twice daily as needed.
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!